Even as Anthropic has tried to clamp down, Business Insider found multiple examples of SPVs being used to market Anthropic shares. Even as Anthropic has tried to clamp down on a popular investment veh...
Omnivision fund ownership grew for six straight quarters, going from under 1 million to nearly 8 million shares traded a week. Information in Investor’s Business Daily is for informational and educati...
Stock Of The Day: Royal Bank of Canada is breaking out into a buy zone to a new high after last year’s strong share and earnings performance. Information in Investor’s Business Daily is for info...
After co-creating Amazon Alexa, William Tunstall-Pedoe became an angel investor. When he started his second business, he drew on the invaluable experience of his mentees. This as-told-to essay is base...
A small business owner warns U.S. Sen. Dave McCormick that broad exemptions in digital asset legislation would create a dangerous shadow market for everyday investors and retirees. Running a small bus...
Medical technology leader Halozyme’s stock is back in a buy zone. The biopharma company gave robust 2027 and 2028 sales forecasts. Information in Investor’s Business Daily is for informational a...
Chipmaker Macom Technology Solutions beat analyst estimates for its fiscal first quarter and with its guidance. Macom stock rose. Information in Investor’s Business Daily is for informational and educ...
Fintech firm Broadridge Financial raised its full-year earnings forecast and posted a higher second-quarter profit on Tuesday, buoyed by strength in its investor communications business. The firm, one...
Merck will report its earnings on Tuesday, offering insights into how its agreement to lower the price of its diabetes drug has impacted its business. Merck could still be a winning stock, despite the...
NovaGold’s chairman told Business Insider that he expects the gold price to be in the “tens of thousands of dollars” in time. Billionaire investor Thomas Kaplan says he’s unfaz...
